SEVORANE 250mg volatile liquid for inhalations medication leaflet

N01AB08 sevoflurane • Nervous system | Anesthetics, general | Halogenated hydrocarbons

Sevoflurane is an inhalation anesthetic agent used for the induction and maintenance of general anesthesia. It works by depressing the central nervous system, inducing a state of unconsciousness and muscle relaxation.

The medication is administered via inhalation under the supervision of an anesthesiologist, usually during surgical procedures. It is important for administration to be performed in controlled conditions to prevent complications.

Patients should be aware of potential side effects, such as nausea, vomiting, or hypotension. It is important to inform the doctor of any unusual symptoms after anesthesia.

Common side effects include nausea, vomiting, and hypotension. In rare cases, severe reactions such as malignant hyperthermia or liver failure may occur. Patients should be informed of these risks before administration.

General data about SEVORANE 250mg

Substance: sevoflurane

Date of last drug list: 01-12-2019

Commercial code: W65263002

Concentration: 250mg

Pharmaceutical form: volatile liquid for inhalations

Packing volume: 250ml

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: AESICA QUEENBOROUGH LIMITED - MAREA BRITANIE

Holder: ABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIA

Number: 7586/2015/02

Shelf life: 3 years

Concentrations available for sevoflurane

100%, 250mg

Other substances similar to sevoflurane